drugset / Trial / NCT06989333

Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis

NCT06989333

Phase 2 Not yet recruiting 10 enrolled Jiuwu Bai
NaSingle-groupOpen-labelTreatment

Summary

This study aims to explore a new therapeutic approach: the feasibility, safety and preliminary efficacy of directly spraying GM-CSF into the airway through bronchoscopy for the treatment of aPAP.

Timeline

Start
2025-07-01
Primary completion
2027-06-30
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject sargramostim Protein / enzyme biologic Other